Skip to content

Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia

Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02481193
Enrollment
90
Registered
2015-06-25
Start date
2013-03-31
Completion date
2014-01-31
Last updated
2015-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fasciculation

Keywords

Cisatracurium, Myalgia, Fasciculation, Succinylcholine

Brief summary

The purpose of this study is to investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations and postoperative myalgia.

Detailed description

Purpose: To investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations and postoperative myalgia. Methods: Ninety patients scheduled for laparoscopic cholecystectomies were equally randomized into three groups to receive pretreatment of 0.005, 0.01, and 0.02 mg/kg cisatracurium, respectively. General anesthesia was induced 3.5 min later, train of four stimulation was monitored 4.5 min later, succinylcholine 1.5 mg/kg was injected 5 min later, and endotracheal intubation was implemented 6.5 min later. The side effects of cisatracurium, intensity of fasciculations, intubating conditions, time and extent to maximal depression of twitch and time for its recovery to 20% of control value, severity of myalgia at 24 h postoperatively, serum potassium before the induction, at the time of endotracheal intubation, and 5 min after intubation were recorded.

Interventions

DRUGCisatracurium

Different doses of cisatracurium pretreatment

Sponsors

Yangzhou No.1 People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* American Standards Association (ASA) physical status I or II patients scheduled for elective laparoscopic cholecystectomies with tracheal intubation requiring general anesthesia * 20 - 65 years old * without acid-base imbalance and electrolyte disturbance * with normal hepatic and renal function

Exclusion criteria

* Patients with known hyperkalemia * Patients with increased intraocular pressure * Patients with increased intracranial pressure * Patients with symptoms of gastroesophageal reflux * Patients with anticipated airway difficulties * Patients with malignant fever * Patients with neuromuscular disease * Patients with burn or crush injuries * Patients with taking drugs known to alter the action of neuromuscular blockers * Patients with with a body mass index exceeding 30

Design outcomes

Primary

MeasureTime frame
The presence of fasciculationsAfter the injection of succinylcholine for 1.5 minutes

Secondary

MeasureTime frame
The time to maximal depression of twitchFrom the time of 4.5 minutes after the pretreatment of cisatracurium for two minutes
The extent to maximal depression of twitchFrom the time of 4.5 minutes after the pretreatment of cisatracurium for two minutes
The time for twitch recovery to 20% of its control valueFrom the time of 4.5 minutes after the pretreatment of cisatracurium for two minutes
Side effects of the pretreatment of cisatracuriumAt the time of three minutes after the pretreatment of cisatracurium
The changes of serum potassiumAfter entering the operating theater till the anesthesia induction, at intubating, and 5 min after intubation
Myalgia at 24 hours postoperativelyAt 24 hours postoperatively
The grades of endotracheal intubationAt intubating time

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026